BioMark Diagnostics Inc C.BUX

Alternate Symbol(s): BMKDF

Biomark Diagnostics Inc. develops early-stage cancer diagnostic technology platform to detect and treat cancer. The company invests in and develops a liquid biopsy metabolic panel assay for the early-stage diagnosis of lung cancer, as well as glioblastoma (GBM), breast cancer, and head and neck cancer. It is also developing liquid biopsy tests for various cancer types, including glioblastoma, gastrointestinal, prostate, head, neck cancers. The company was incorporated in 2014 and is headquartered in Richmond, Canada.

CSE:BUX - Post by User

BioMark Diagnostics Inc

<< Previous

Bullboard Posts

Next >>

(54)
•••

Post by geodcanon Mar 21, 2023 4:08pm

180 Views

Post# 35352101

Some optimistic

nrs in regards to progress and optimism but not enough promo from BOD to generate any new interest from investors.

Artificially supported shareprice with near zero volume screams for a breakthrough development or more promotional management.

<< Previous

Bullboard Posts

Next >>

Volatus Aerospace reports record Q1 margins as strategic expansion accelerates